Mild cognitive impairment

CONTINUUM Lifelong Learning in Neurology

Volumn 19, Issue 2, 2013, Pages 411-424

  Lopez, Oscar L ^a  

^a Oxford Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN[1-42]; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; CELECOXIB; CHOLINESTERASE INHIBITOR; DONEPEZIL; FLUORODEOXYGLUCOSE; GINKGO BILOBA EXTRACT; NAPROXEN; PITTSBURGH COMPOUND B; PLACEBO; ROFECOXIB; SERTRALINE; TAU PROTEIN;

ALZHEIMER DISEASE; BRAIN REGION; CEREBROSPINAL FLUID LEVEL; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); COGNITION; COMORBIDITY; DAILY LIFE ACTIVITY; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; DRUG DOSE INCREASE; HUMAN; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NERVE DEGENERATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PREVALENCE; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BIOLOGICAL MARKERS; DEMENTIA; DISEASE PROGRESSION; HUMANS; MENTAL DISORDERS; MILD COGNITIVE IMPAIRMENT; NERVOUS SYSTEM DISEASES;

EID: 84876395288     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000429175.29601.97     Document Type: Review

References (85)

1. Kaszniak AW, Poon LW, Riege W. Assessing memory deficits: an information-processing approach. In: Poon LW, ed. Handbook for clinical memory assessment of older adults. Washington, DC: American Psychological Association, 1986.
2. Rubin EH, Storandt M, Kinscherf DA, et al. A prospective study of cognitive function and onset of dementia in cognitively healthy elders. Arch Neurol 1998;55(3):395-401.
3. Bowen J, Teri L, Kukull W, et al. Progression to dementia in patients with isolated memory loss. Lancet 1997;349(9054):763-765.
4. Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001;58(3): 397-405.
5. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 1999;56(3):303-308.
6. Lopez OL, Jagust WJ, DeKosky ST, et al. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognitive Study: part 1. Arch Neurol 2003;60(10):1385-1389.
7. Tierney MC, Szalai JP, Snow WG, et al. Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology 1996;46(3): 661-665.
8. Hanninen T, Hallikainen M, Koivisto K, et al. A follow-up study of age-associated memory impairment: neuropsychological predictors of dementia. J Am Geriatr Soc 1995;43(9): 1007-1015.
9. Ganguli M, Dodge HH, Shen C, DeKosky ST. Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology 2004; 63(1):115-121.
10. Lopez OL, Becker JT, Chang YF, et al. Incidence of mild cognitive impairment in the Pittsburgh Cardiovascular Health Study-Cognition Study. Neurology 2012; 79(15):1599-1606.
11. Blackford RC, LaRue A. Criteria for diagnosing age associated memory impairment: proposed improvements from the field. Dev Neuropsychol 1989;5(4):295-306.
12. Crook TH, Bartus RT, Ferris SH, et al. Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change. Report of a National Institute of Mental Health Work Group. Dev Neuropsychol 1986;2(4):261-276.
13. Graham JE, Rockwood K, Beattie EL. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997; 349(9068):1793-1796.
14. Kral VA. Senescent forgetfulness: benign and malignant. Can Med Assoc J 1962;86:257-260.
15. Petersen RC, Smith GE, Waring SC, et al. Aging, memory, and mild cognitive impairment. Int Psychogeriatr 1997;9(suppl 1):65-69.
16. Levy R. Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr 1994;6(1):63-68.
17. American Psychiatric Association. DSM-IV: diagnostic and statistic manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994.
18. Lopez OL, Kuller LH, Becker JT, et al. Incidence of dementia in mild cognitive impairment in the cardiovascular health study. Arch Neurol 2007;64(3):416-420.
19. Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology 1991;41(7):1006-1009.
20. World Health Organization. The ICD-10 classification of mental and behavioral disorders: diagnostic criteria for research. Geneva, Switzerland: World Health Organization, 1993.
21. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256(3): 183-194.
22. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairmentVbeyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256(3):240-246.
23. O'Brien JT, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment. Lancet Neurol 2003;2(2):89-98.
24. Albert MS, Dekosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging and Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7(3):270-279.
25. Becker JT, Lopez OL, Wess J. Material-specific memory loss in probable Alzheimer's disease. J Neurol Neurosurg Psychiatry 1992;55(12): 1177-1181.
26. Ebly EM, Hogan DB, Parhad IM. Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging. Arch Neurol 1995;52(6):612-619.
27. Schmand B, Jonker C, Geerlings MI, Lindeboom J. Subjective memory complaints in the elderly: depressive symptoms and future dementia. Br J Psychiatry 1997;171: 373-376.
28. Jorm AF, Christensen H, Korten AE, et al. Do cognitive complaints either predict future cognitive decline of reflect past cognitive decline? A longitudinal study of an elderly community sample. Psychol Med 1997;27(1): 91-98.
29. Smith GE, Petersen RC, Ivnik RJ, et al. Subjective memory complaints, psychological distress, and longitudinal change in objective memory performance. Psychol Aging 1996; 11(2):272-279.
30. Jessen F, Wiese B, Bachmann C, et al. Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment. Arch Gen Psychiatry 2010;67(4): 414-422.
31. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12(3):189-198.
32. Howieson DB, Dame A, Camicioli R, et al. Cognitive markers preceding Alzheimer's dementia in the healthy oldest old. J Am Geriatr Soc 1997;45(5):584-589.
33. Schmand B, Jonker C, Hooijer C, Lindeboom J. Subjective memory complaints may announce dementia. Neurology 1996;46(1):121-125.
34. Hanninen MA, Hallikainen M, Koivisto K, et al. Decline of frontal lobe functions in subjects with age-associated memory impairment. Neurology 1997;48(1):148-153.
35. Chen P, Ratcliff G, Belle SH, et al. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology 2000;55(12): 1847-1853.
36. Snitz BE, Saxton J, Lopez OL, et al. Identifying mild cognitive impairment at baseline in the Ginkgo Evaluation of Memory (GEM) study. Aging Ment Health 2009;13(2):171-182.
37. Butters MA, Becker JT, Nebes RD, et al. Changes in cognitive functioning following treatment of late-life depression. Am J Psychiatry 2000;157(12):1949-1954.
38. DeCarli C, Miller BL, Swan GE, et al. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol 2001; 58(4):643-647.
39. Chetelat G, Desgranges B, de la Sayette V, et al. Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology 2003;60(8):1374-1377.
40. Jack CR Jr, Wiste HJ, Vemuri P, et al. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Brain 2010;133(11):3336-3348.
41. Hansson O, Zetterberg H, Buchhave P, et al. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 2006;5(3):228-234.
42. Wolk DA, Price JC, Saxton J, et al. Amyloid imaging in mild cognitive impairment subtypes. Ann Neurol 2009;65(5):557-568.
43. Clark CM, Xie S, Chittams J, et al. Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol 2003;60(12):1696-1702.
44. Ewers M, Walsh C, Trojanowski JQ, et al. Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol Aging 2010; 33(7):1203-1214.
45. Raji CA, Lee C, Lopez OL, et al. Initial experience in using continuous arterial spin-labeled MR imaging for early detection of Alzheimer disease. AJNR Am J Neuroradiol 2010;31(5):847-855.
46. Chetelat G, Desgranges B, de la Sayette V, et al. Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. Neuroreport 2002;13(15): 1939-1943.
47. Laakso MP, Soininen H, Partanen K, et al. MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects. Neurobiol Aging 1998;19(1):23-31.
48. Csernansky JG, Wang L, Joshi S, et al. Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus. Neurology 2000;55(11):1636-1643.
49. Soininen HS, Partanen K, Pitkanen A, et al. Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: correlation to visual and verbal memory. Neurology 1994;44(9):1660-1668.
50. Bell-McGinty S, Lopez OL, Meltzer CC, et al. Differential cortical atrophy in subgroups of mild cognitive impairment. Arch Neurol 2005;62(9):1393-1397.
51. de Leon MJ, Golomb J, George AE, et al. The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. AJNR Am J Neuroradiol 1993;14(4):897-906.
52. Jack CR, Petersen RC, Xu YC, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999;52(7):1397-1403.
53. Killiany RJ, Gomez-Isla T, Moss M, et al. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol 2000;47(4):430-439.
54. Convit A, de Asis J, de Leon MJ, et al. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Neurobiol Aging 2000; 21(1):19-26.
55. Pennanen C, Kivipelto M, Tuomainen S, et al. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging 2004;25(3):303-310.
56. Chetelat G, Baron JC. Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging. Neuroimage 2003; 18(2):525-541.
57. Karas GB, Scheltens P, Rombouts SARB, et al. Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage 2004;23(2):708-716.
58. Kaye JA, Swihart T, Howieson D, et al. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology 1997;48(5):1297-1304.
59. Stoub TR, Bulgakova M, Leurgans S, et al. MRI predictors of risk of incident Alzheimer disease: a longitudinal study. Neurology 2005;64(9):1520- 1524.
60. Jack CR, Petersen RC, Xu Y, et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 2000;55(4):484-489.
61. Carmichael OT, Kuller LH, Lopez OL, et al. Cerebral ventricular changes associated with transitions between normal cognitive function, mild cognitive impairment, and dementia. Alzheimer Dis Assoc Disord 2007;21(1):14-24.
62. Chetelat G, Desgranges B, de la Sayette V, et al. Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment. Brain 2003;126(pt 9):1955-1967.
63. Drzezga A, Grimmer T, Riemenschneider M, et al. Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)-FDG PET. J Nucl Med 2005;46(10):1625-1632.
64. McKelvey R, Bergman H, Stern J, et al. Lack of prognostic significance of SPECT abnormalities in non-demented elderly subjects with memory loss. Can J Neurol Sci 1999;26(1):23-28.
65. Dickerson BC, Salat DH, Greve DN, et al. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology 2005;65(3):405-411.
66. Rosano C, Aizenstein HJ, Cochran J, et al. Event-related functional magnetic resonance imaging investigation of executive control in very old individuals with mild cognitive impairment. Biol Psychiatry 2005;57(7):761-767.
67. Dai W, Lopez OL, Carmichael OT, et al. Mild cognitive impairment and Alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology 2009;250(3):856-866.
68. Clark CM, Schneider JA, Bedell BJ, et al. Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA 2011;305(3):275-283.
69. Jack CR Jr, Lowe VJ, Weigand SD, et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 2009; 132(pt 5):1355-1365.
70. Cohen AD, Price JC, Weissfeld LA, et al. Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve. J Neurosci 2009;29(47):14770-14778.
71. Oh H, Habeck C, Madison C, et al. Covarying alterations in Abeta deposition, glucose metabolism, and gray matter volume in cognitively normal elderly. Hum Brain Mapp 2012, In press.
72. Salloway S, Ferris S, Kluger A, et al. Efficacy of donepezil in mild cognitive impairment. A randomized placebo-controlled trial. Neurology 2004;63(4):651-657.
73. Doody RS, Ferris SH, Salloway S, et al. Donepezil treatment of patients with MCI. A 48-week randomized, placebo-controlled trial. Neurology 2009;72(18):1555-1161.
74. Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005;352(23):2379-2388.
75. Feldman HH, Ferris S, Winblad B, et al. Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Lancet Neurol 2007;6(6):501-512.
76. Winblad B, Gauthier S, Feldman H, et al. Safety and efficacy of galantamine in subjects with mild cognitive impairment. Neurology 2008;70(22):2-24-2035.
77. Lu PH, Edland SD, Teng E, et al. Donepezil delays progression to AD in MCI subjects with depressive symptoms. Neurology 2009; 72(24):2115-2121.
78. Reynolds CF 3rd, Butters MA, Lopez O, et al. Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy. Arch Gen Psychiatry 2011;68(1):51-60.
79. Aisen PS, Thal LJ, Ferris SH, et al. Rofecoxib in patients with mild cognitive impairment: further analyses of data from a randomized, double-blind, trial. Curr Alzheimer Res 2008;5(1):73-82.
80. ADAPT Research Group;Lyketsos CG, Breitner JC, Green RC, et al. Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology 2007;68(21):1800-1808.
81. DeKosky ST, Williamson JD, Fitzpatrick AL, et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial [erratum published in JAMA 2008;300(23): 2730]. JAMA 2008;300(19):2253-2262.
82. Vellas B, Coley N, Ousset PJ, et al. Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol 2012;11(10):851-859.
83. Verghese J, Lipton RB, Katz MJ, et al. Leisure activities and the risk of dementia in the elderly. N Engl J Med 2003;348(25):2508-2516.
84. Erickson KI, Raji CA, Lopez OL, et al. Physical activity predicts gray matter volume in late adulthood: the Cardiovascular Health Study. Neurology 2010;75(16):1415-1422.
85. Geda YE, Roberts RO, Knopman DS, et al. Physical exercise, aging, and mild cognitive impairment: a population-based study. Arch Neurol 2010;67(1):80-86.